A 23-year-old womanwas admitted to our hospital with recurrent gouty arthritis. Laboratory findings showed hypoglycemia, lactic acidosis, hyperlipidemia, and hyperuricemia, with normal values of serum al fa-fetoprotein (AFP) and protein induced by vitamin K absence (PIVKA-II). A diagnosis of glycogen storage disease type I (GSD-type I) was made on the basis of the laboratory data, liver biopsy findings, and partially deficient thrombocyte glucose-6-phosphatase (G-6-Pase) activity. Ultrasonography and computed tomography revealed multiple focal hepatic masses. Biopsied specimens of the lesion demonstrated a hepatic adenoma,whichchanged in appearance in the relatively short period between echography and computed tomography. This interesting phenomenonmayhighlight the importance for careful follow-up of hepatic adenomas, because of the potential of rupture, hemorrhage, or malignant transformation. During follow-up, the present patient received hemodialysis due to renal failure, and the adenoma regressed spontaneously after 8 years. Included are diagnostic images, demonstrating the association of hepatic adenoma and GSD-type I. (Internal Medicine 40: 891-895, 2001) 
Introduction
Glycogen storage disease type I (GSD-type I) (glucose-6-phosphatase deficiency) is a metabolic disorder of autosomal recessive inheritance characterized by hypoglycemia, hepatomegaly, and growth retardation. Manypatients with this disease suffer from severe acidosis or hypoglycemia in their childhood. However, recent advances in nutritional support preventing nocturnal hypoglycemia have obtained longer survival times for GSD-type I patients to adolescence and even adulthood. As a result, in older patients, other complications such as gout, hyperlipidemia, and hepatic tumors are frequently observed. Previously, hepatic adenomawas considered to be a rare complication of GSD-type I, but has recently been recognized more frequently with the development of diagnostic techniques.
We encountered a case of GSD-type I complicated with a hepatic adenoma, which changed its appearance in a relatively short period of time between ultrasonography and computed tomography, and then naturally regressed after 8 years, during which time the patient received hemodialysis.
Case Report
A 23-year-old womanwas referred to our gout clinic in October 1 990 for the management of recurrent gouty arthritis. She had a 10-year history of gout, which had been resistant to medical therapy. The patient was a first child of unrelated parents and her birth was uneventful. There was no particular family history of note. She has not used oral contraceptives. A physical examination showed that the patient was apparently in good health. She was 167 cm tall and weighed 69 kg with normal vital signs. The abdomen was soft and nontender, however, her liver could be palpated 3 cm below the right costal margin at the mid-clavicular line. Neither kidney was palpable. Swelling and redness of the metatarsophalangeal (MTP) joint of the right great toe was also noted. Other clinical examinations were normal. Her red blood cell count was 3O5xlO4/mm3,hemoglobin level 8.9 g/dl, platelet count 65.5xlO4/mm3, and white blood cell count 1 0,500/mm3 with a normal differential. , except for the nodular lesions, disclosed liver cells crowdedwith glycogen, but the nature of the specimen biopsied from the largest mass could not be diagnosed. The patient was followed by ultrasonographic and CTexaminations; her findings remained unchanged during the followup period. Serial ultrasonography, however, showed a progressive increase in the size and echogenic alteration of the largest mass in the left lobe, suggesting a malignant transformation. The largest nodule became heterogeneous with a thin hypoechoic rim 13 months later (Fig. 2 middle) . However, ultrasonographic findings of other small nodules, especially in the right lobe, suggested a benign hepatic adenoma. The high density mass in the left lobe (Fig. 3 upper) showed a low density area measuring 3 cm in diameter on CT scan (Fig. 3 middle) . A dynamic CTscan disclosed that the tumor had enhanced rapidly to become hyperdense, followed by a gradual decline in density. At this time (April 7, 1992), the specimens biopsied from the largest mass disclosed normal appearing liver cells without bile ducts or portal areas, consistent with hepatic adenoma (Fig. 4) . Anoperation was not performed, because of the multiple hepatic lesions, and the patient was again followed using ultrasonographic examinations. Her renal function gradually deteriorated during this observation period, and she was obliged to undergohemodialysis at another hemodialysis center. Seven and half years later, she was referred again to our hospital to apply for kidney transplantation. At the time of this report (April 27, 2000), laboratory data showed fasting blood sugar at 75 mg/dl, serum uric acid at 8. 1 mg/dl, serum creatinine at 6.4 mg/dl, urea nitrogen at 48.0 mg/dl, glucagon 79 pg/ ml, and lactic acid at 16.2 mg/dl. Interestingly, the most recent Regression on Hepatic Adenoma ultrasonography and CTscan demonstrated a regression of the adenoma in the left lateral segment of the liver (Fig. 2 lower; 
Discussion
Sumitomoet al (1) reviewed 50 cases of hepatic tumors associated with GSD-type I in 1988. Amongthem, a histological diagnosis of the tumor was documented in 22 cases. They consisted of 16 cases ofhepatic adenoma (73%), 3 cases ofhepatocellular carcinoma (14%), 2 cases of focal nodular hyperplasia (FNH) (9%), and 1 case of hepatoblastoma (4%). Occurrences of hepatic adenomain GSD-typeI have been extensively studied since the first case was reported in 1955 (2) . The development of GSD-type I adenomatous nodules in the liver has been regarded as an infrequent occurrence, however, a recent report suggested a higher incidence (50-80%), particularly in patients whoare over 10 years of age (3). Detection of hepatic adenomain patients with GSD-typeI have been accomplished with the use of ultrasonography, hepatic scintigraphy, and computed tomography. However, in view of their sensitivity for detection of small hepatic lesions, ultrasonography or computed tomography is superior to hepatic scintigraphy. On ultrasonography, a hepatic adenoma unassociated with glycogen storage disease is echogenic, with or without hypoechoic components. However, hepatic adenomas associated with GSD-type I have been described as hypoechoic (4), and in larger adenomas a heterogeneous echogenic or hypoechoic pattern has been observed along with the overall echogenecity (5), which is presumed to be secondary to necrosis, hemorrhaging or both, though the ultrasonographic appearance of GSD-type I hepatic adenomas has been described in only a few reports. Bowermanet al (6) also mentionedthat the presence of an echogenic or heterogeneous solid mass with enhancedsound transmission suggests hepatic adenoma in a GSD-type I patient. Moreover, a few studies have reported CTfindings of the liver in GSD-typeI. Hepatic adenomasin GSD-typeI showno consistent features on a precontrast CTscan. Someare hypodense (7), while others are hyperdense or isodense (8) , though a hepatic adenoma may be suggested when hemorrhage foci are detected. Unfortunately, reports concerning the CTfeatures of hepatic adenoma in GSDtype I are too few to give sufficient precise information, therefore it may be difficult at this time to diagnose hepatic adenoma on CTfindings alone. In contrast, a dynamic CTscan seems to give significant information for obtaining an exact diagnosis. Rapid enhancement to hyperdensity followed by a slow decline in density allows a reliable diagnosis, and an accumulation of imaging examination results for hepatic adenomaand/ or carcinoma in GSD-type I will serve to provide guidelines for a correct diagnosis. Hepatic adenomain GSD-typeI is considered to be a premalignant lesion, as it has been reported that some patients with adenoma develop hepatocellular carcinomas later (8) .
Malignant transformation has been suggested, with an increase in size and number of tumors, and a loss of demarcation of the tumors. In the present case, the ultrasonographic appearance of the tumor changed from hypoechoic to heterogeneous, and the CTappearance changed from hyperdense to hypodense with an increase in size. Although both of these interesting findings were difficult to differentiate from malignant transformation, a tissue diagnosis suggested hepatic adenoma. The pathogenesis of hepatic adenomain GSD-typeI remains incompletely understood, though the association between hepatic adenomaand the use of oral contraceptives is well known. Recurrent and prolonged hypoglycemia with secondary stimulation such as glucagon, epinephrine, or insulin has been postulated to be responsible for the development of hepatic adenoma in GSD-type I. In contrast, however, a regression of hepatic adenomas with dietary therapy or nightly glucose infusion has been reported (9) . Correction of the glucose/insulin ratio, glycogen overload, and abnormal long-fatty acid metabolism maybe associated with the resolution of hepatic adenoma. The present case also showeda natural regression 8 years later, but the exact mechanism of regression remainsunclear, since the hypoglycemia was mild and the patient did not require special dietary therapy or nightly glucose infusion. It is possible that hemodialysis may have had some favorable effect, by correcting some metabolic imbalance.
In conclusion, late complications such as gout, hyperlipidemia, and hepatic tumor are considered important prognostic factors for longer survival in GSD-type I. Particularly, multicentric hepatic adenomasseen by ultrasonography are considered premalignant, therefore, it is imperative that all GSD-type I patients be closely followed by the use of ultrasonography or CTscan, and further, that correction of metabolic imbalance, such as hypoglycemia with dietary therapy, should be done as early as possible to prevent the development of hepatic adenomasor induce their resolution.
